PMVP PMV Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 14, 2026
$1,79
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$1,02Bas 52 semaines
$1,91Haut 52 semaines
Capitalisation Boursière (MRQ)
$96M
P/E
-1.2
BPA
$-1.48
vos badges
Fourchette 52 semaines
$1–$2
Note des analystes
BUY
Objectif de cours
$4
P/E
-1.2
ROE
-63.4%
Marge nette
-1226.8%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
PMVP Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$1.79
Capitalisation Boursière (MRQ)
$96M
P/E
-1.2
BPA
$-1.48
ROE
-63.4%
Fourchette 52 semaines
$1–$2
PMVP Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
BPA$-1.482020-12-31 → 2025-12-31
Flux de trésorerie libre$-74M2020-12-31 → 2025-12-31
Marge nette-1226.8%2020-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | PMVP | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E | -1.2moyenne 5 ans ≈-5.6 | ≈-5.6 | · | · | |
| P/S | 15.1moyenne 5 ans ≈495.9 | ≈495.9 | 73.7 | Sous-évalué | |
| P/B (MRQ) | 1.3moyenne 5 ans ≈1.4 | ≈1.4 | 2.5 | Sous-évalué | |
| Cours / FCF (TTM) | -1.3moyenne 5 ans ≈-6.5 | ≈-6.5 | · | · | |
| Cours / Flux de trésorerie (TTM) | -1.3moyenne 5 ans ≈-6.8 | ≈-6.8 | · | · | |
| Price / Tangible Book (Cours / Actif net tangible) | 0.9moyenne 5 ans ≈1.4 | ≈1.4 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | PMVP | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Operating Margin (Marge d'exploitation) | -1360.4%moyenne 5 ans ≈-3597.3% | ≈-3597.3% | -3199.0% | Premier rang | |
| EBITDA Margin (Marge EBITDA) | -1360.4%moyenne 5 ans ≈-3597.3% | ≈-3597.3% | -3199.0% | Premier rang | |
| Pretax Margin (Marge avant impôts) | -1261.1%moyenne 5 ans ≈-3496.1% | ≈-3496.1% | -2294.8% | En ligne | |
| Net Profit Margin (Marge nette) | -1226.8%moyenne 5 ans ≈-3460.0% | ≈-3460.0% | -2452.9% | En ligne | |
| ROA | -50.5%moyenne 5 ans ≈-28.9% | ≈-28.9% | -57.6% | En ligne | |
| ROE | -63.4%moyenne 5 ans ≈-34.3% | ≈-34.3% | -63.4% | En ligne | |
| ROIC | -80.1%moyenne 5 ans ≈-40.8% | ≈-40.8% | -68.6% | Inférieur à la moyenne |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | PMVP | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Ratio de liquidité (MRQ) | 7.7moyenne 5 ans ≈16.9 | ≈16.9 | 7.7 | En ligne | |
| Quick Ratio (Ratio de liquidité réduite) | 9.9moyenne 5 ans ≈16.5 | ≈16.5 | 7.5 | En ligne |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | PMVP | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | -40.5%moyenne 5 ans ≈167.9% | ≈167.9% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | 20.4%moyenne 5 ans ≈121.9% | ≈121.9% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 57.6% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | PMVP | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.0moyenne 5 ans ≈0.0 | ≈0.0 | 0.0 | Premier rang |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
9.8%
Prochain rapport
Nov 10, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Aoû 14, 2026 | $-0.34 | $-0.40 | 14.0% |
| 31 mars 2026 | Mai 8, 2026 | $-0.34 | $-0.42 | 18.7% |
| 31 décembre 2025 | $-0.34 | $-0.41 | 17.7% | |
| 30 septembre 2025 | $-0.40 | $-0.41 | 2.6% | |
| 30 juin 2025 | $-0.41 | $-0.39 | -4.9% | |
| 31 mars 2025 | $-0.34 | $-0.38 | 11.0% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $70M | $59M | $56M | $52M | $36M | $24M | $21M | |
| SG&A Expense | $16M | $27M | $24M | $25M | $22M | $11M | $6M | |
| Operating Expenses | $86M | $85M | $80M | $77M | $58M | $35M | $27M | |
| Operating Income | $-86M | $-85M | $-80M | $-77M | $-58M | $-35M | $-27M | |
| Other Non-op | $6M | $11M | $11M | $4M | $470.0K | $508.0K | $1M | |
| Pretax Income | $-80M | $-75M | $-69M | $-73M | $-58M | $-34M | $-25M | |
| Income Tax | $-2M | $-16M | $2.0K | $-9.0K | $23.0K | $6.0K | $8.0K | |
| Net Income | $-78M | $-59M | $-69M | $-73M | $-58M | $-34M | $-25M | |
| EPS (Basic) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | · | |
| EPS (Diluted) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | · | |
| Shares (Basic) | 52,541,613 | 51,578,807 | 48,014,645 | 45,594,824 | 45,137,656 | 14,364,475 | · | |
| Shares (Diluted) | 52,541,613 | 51,578,807 | 48,014,645 | 45,594,824 | 45,137,656 | 14,364,475 | · | |
| EBITDA | $-86M | $-85M | $-80M | $-77M | $-58M | $-35M | · |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $41M | $38M | $108M | $172M | $361M | $73M | |
| Short-term Investments | $75M | $129M | $165M | $133M | $125M | · | · | |
| Prepaid Expense | $2M | $6M | $4M | $5M | $3M | $3M | $607.0K | |
| Current Assets | $115M | $176M | $207M | $247M | $301M | $365M | $102M | |
| PP&E (Net) | $237.0K | $409.0K | $11M | $11M | $3M | $569.0K | $739.0K | |
| PP&E (Gross) | $2M | $2M | $14M | $13M | $5M | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | $3M | $2M | $2M | $2M | $1M | |
| Other Non-current Assets | $297.0K | $235.0K | $190.0K | $313.0K | $221.0K | $201.0K | $201.0K | |
| Total Assets | $117M | $191M | $252M | $270M | $332M | $366M | $103M | |
| Accounts Payable | $3M | $7M | $3M | $3M | $3M | $2M | $3M | |
| Accrued Liabilities | $8M | $7M | $10M | $7M | $9M | $5M | $2M | |
| Current Liabilities | $11M | $14M | $14M | $11M | $12M | $6M | $5M | |
| Capital Leases | $435.0K | $838.0K | $12M | $13M | $11M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $51.0K | |
| Total Liabilities | $12M | $15M | $26M | $24M | $23M | $6M | $5M | |
| Retained Earnings | $-446M | $-369M | $-310M | $-241M | $-168M | $-110M | $-75M | |
| AOCI | $84.0K | $139.0K | $224.0K | $-445.0K | $-78.0K | · | $-3.0K | |
| Stockholders' Equity | $105M | $176M | $226M | $246M | $309M | $359M | $-70M | |
| Liabilities + Equity | $117M | $191M | $252M | $270M | $332M | $366M | $103M | |
| Shares Outstanding | 53,331,766 | 51,935,134 | 51,445,862 | 45,771,332 | 45,433,684 | 44,777,818 | 3,046,200 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $9M | $12M | $10M | $5M | $2M | $908.0K | |
| Operating Cash Flow | $-74M | $-51M | $-56M | $-64M | $-47M | $-33M | $-22M | |
| CapEx | $29.0K | $655.0K | $962.0K | $8M | $1M | $148.0K | $109.0K | |
| Investing Cash Flow | $70M | $53M | $-51M | $-1M | $-144M | $28M | $3M | |
| Stock Issued | · | · | $35M | · | · | $223M | · | |
| Net Stock Activity | · | · | $35M | · | · | $223M | · | |
| Financing Cash Flow | $505.0K | $313.0K | $36M | $958.0K | $2M | $293M | $62M | |
| Net Change in Cash | $-3M | $2M | $-71M | $-64M | $-188M | $288M | $43M | |
| Taxes Paid | · | · | · | · | $23.0K | $6.0K | $8.0K | |
| Free Cash Flow | $-74M | $-52M | $-57M | $-72M | $-48M | $-33M | · |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1360.4% | -802.0% | -717.3% | -2124.1% | -12982.8% | -5367.4% | · | |
| Net Margin | -1226.8% | -551.0% | -617.3% | -2021.4% | -12883.3% | -5290.3% | · | |
| Pretax Margin | -1261.1% | -702.1% | -617.3% | -2021.7% | -12878.2% | -5289.4% | · | |
| EBITDA Margin | -1360.4% | -802.0% | -717.3% | -2124.1% | -12982.8% | -5367.4% | · | |
| ROA | -50.5% | -26.5% | -26.4% | -24.4% | -16.6% | -14.7% | · | |
| ROE | -63.4% | -31.4% | -29.8% | -28.9% | -18.3% | -9.5% | · | |
| ROIC | -80.1% | -38.1% | -35.5% | -31.3% | -18.9% | -9.7% | · |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.1 | 12.2 | 14.8 | 22.8 | 24.7 | 56.9 | · | |
| Quick Ratio | 9.9 | 11.8 | 14.5 | 22.3 | 24.3 | 56.4 | · |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.96 | $3.39 | $4.39 | $5.38 | $6.79 | $8.02 | · | |
| Revenue / Share | $0.12 | $0.21 | $0.23 | $0.08 | · | · | · | |
| Cash Flow / Share | $-1.40 | $-0.99 | $-1.16 | $-1.40 | · | · | · | |
| Cash / Share | $0.71 | $0.79 | $0.73 | $2.37 | $3.80 | $8.07 | · | |
| EPS (TTM) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | · |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -40.5% | -4.6% | 208.0% | 707.8% | -31.0% | · | · | |
| Revenue CAGR 3Y | 20.4% | 187.4% | 157.9% | · | · | · | · | |
| Revenue CAGR 5Y | 57.6% | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $11M | $11M | $4M | $449.0K | $651.0K | · | |
| Net Income TTM | $-78M | $-59M | $-69M | $-73M | $-58M | $-34M | · | |
| Market Cap | $67M | $78M | $159M | $398M | $1.05B | $2.75B | · | |
| P/E | -0.8 | -1.3 | -2.2 | -5.4 | -18.0 | -25.6 | · | |
| P/S | 10.5 | 7.4 | 14.3 | 109.8 | 2337.5 | 4230.9 | · | |
| P/B | 0.6 | 0.4 | 0.7 | 1.6 | 3.4 | 7.7 | · | |
| P / Tangible Book | 0.6 | 0.4 | 0.7 | 1.6 | 3.4 | 7.7 | · | |
| P / Cash Flow | -0.9 | -1.5 | -2.9 | -6.2 | -22.5 | -84.1 | · | |
| P / FCF | -0.9 | -1.5 | -2.8 | -5.6 | -21.9 | -83.7 | · | |
| Earnings Yield | -118.4% | -75.5% | -46.5% | -18.5% | -5.5% | -3.9% | · |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $15M | $16M | $18M | $18M | $17M | $14M | $17M | $15M | $13M | $14M | $14M | $15M | $14M | $11M | $12M | |
| SG&A Expense | $4M | $4M | $3M | $4M | $4M | $4M | $11M | $5M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $7M | |
| Operating Expenses | $19M | $19M | $19M | $23M | $23M | $22M | $25M | $22M | $20M | $18M | $20M | $20M | $21M | $19M | $18M | $19M | |
| Operating Income | $-19M | $-19M | $-19M | $-23M | $-23M | $-22M | $-25M | $-22M | $-20M | $-18M | $-20M | $-20M | $-21M | $-19M | $-18M | $-19M | |
| Other Non-op | $798.0K | $981.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $1M | $573.0K | $188.0K | |
| Pretax Income | $-18M | $-18M | $-18M | $-21M | $-21M | $-20M | $-23M | $-19M | $-17M | $-15M | $-17M | $-17M | $-19M | $-18M | $-17M | $-18M | |
| Income Tax | $3.0K | · | $26.0K | $-6.0K | $5.0K | $-2M | $0 | $74.0K | $-16M | · | $-1.0K | $4.0K | · | $-9.0K | $-2.0K | $2.0K | |
| Net Income | $-18M | $-18M | $-18M | $-21M | $-21M | $-17M | $-23M | $-19M | $-1M | $-15M | $-17M | $-17M | $-19M | $-18M | $-17M | $-18M | |
| EPS (Basic) | $-0.34 | $-0.34 | $-0.33 | $-0.40 | $-0.41 | $-0.34 | $-0.45 | $-0.37 | $-0.02 | $-0.30 | $-0.34 | $-0.38 | $-0.42 | $-0.40 | $-0.38 | $-0.41 | |
| EPS (Diluted) | $-0.34 | $-0.34 | $-0.33 | $-0.40 | $-0.41 | $-0.34 | $-0.45 | $-0.37 | $-0.02 | $-0.30 | $-0.34 | $-0.38 | $-0.42 | $-0.40 | $-0.38 | $-0.41 | |
| Shares (Basic) | 53,386,909 | 53,331,766 | · | 52,993,238 | 52,010,827 | 51,952,062 | · | 51,574,027 | 51,478,751 | 51,445,862 | 49,047,296 | 45,813,132 | 45,773,357 | 45,622,957 | 45,571,067 | 45,466,044 | |
| Shares (Diluted) | 53,386,909 | 53,331,766 | · | 52,993,238 | 52,010,827 | 51,952,062 | · | 51,574,027 | 51,478,751 | 51,445,862 | 49,047,296 | 45,813,132 | 45,773,357 | 45,622,957 | 45,571,067 | 45,466,044 | |
| EBITDA | $-19M | $-19M | · | $-23M | $-23M | $-22M | · | $-22M | $-20M | $-18M | $-20M | $-20M | $-21M | $-19M | $-18M | $-19M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $39M | $38M | $36M | $44M | $51M | $41M | $49M | $49M | $48M | $52M | $68M | $143M | $100M | $87M | $116M | |
| Short-term Investments | $67M | $54M | $75M | $93M | $98M | $109M | $129M | $134M | $164M | $150M | $150M | $119M | $86M | $159M | $190M | $167M | |
| Prepaid Expense | $2M | $2M | $2M | $3M | $3M | $3M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $5M | $4M | $4M | |
| Current Assets | $81M | $96M | $115M | $132M | $145M | $163M | $176M | $190M | $219M | $202M | $205M | $190M | $233M | $265M | $282M | $288M | |
| PP&E (Net) | $154.0K | $203.0K | $237.0K | $255.0K | $287.0K | $376.0K | $409.0K | $10M | $11M | $11M | $11M | $11M | $11M | $10M | $9M | $5M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $14M | $15M | $15M | $14M | $14M | $14M | $12M | $11M | $7M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $296.0K | $296.0K | $297.0K | $249.0K | $248.0K | $237.0K | $235.0K | $242.0K | $182.0K | $182.0K | $180.0K | $181.0K | $314.0K | $307.0K | $308.0K | $221.0K | |
| Total Assets | $82M | $97M | $117M | $134M | $153M | $171M | $191M | $223M | $238M | $237M | $261M | $242M | $254M | $285M | $301M | $315M | |
| Accounts Payable | $2M | $2M | $3M | $3M | $3M | $4M | $7M | $2M | $5M | $859.0K | $2M | $3M | $2M | $5M | $3M | $5M | |
| Accrued Liabilities | $8M | $7M | $8M | $9M | $9M | $6M | $7M | $10M | $6M | $10M | $9M | $8M | $9M | $6M | $8M | $7M | |
| Current Liabilities | $11M | $9M | $11M | $12M | $12M | $10M | $14M | $14M | $11M | $12M | $11M | $11M | $11M | $12M | $11M | $12M | |
| Capital Leases | $0 | $0 | $435.0K | $541.0K | $643.0K | $742.0K | $838.0K | $12M | $12M | $12M | $13M | $13M | $13M | $12M | $12M | $11M | |
| Total Liabilities | $11M | $9M | $12M | $13M | $12M | $11M | $15M | $26M | $23M | $24M | $23M | $24M | $24M | $24M | $24M | $23M | |
| Retained Earnings | $-483M | $-464M | $-446M | $-428M | $-407M | $-386M | $-369M | $-346M | $-326M | $-325M | $-294M | $-278M | $-260M | $-222M | $-203M | $-186M | |
| AOCI | $-82.0K | $-15.0K | $84.0K | $91.0K | $21.0K | $84.0K | $139.0K | $410.0K | $-185.0K | $-129.0K | $-355.0K | $-328.0K | $-116.0K | $-1M | $-1M | $-666.0K | |
| Stockholders' Equity | $72M | $88M | $105M | $121M | $141M | $160M | $176M | $198M | $214M | $213M | $238M | $218M | $230M | $261M | $277M | $292M | |
| Liabilities + Equity | $82M | $97M | $117M | $134M | $153M | $171M | $191M | $223M | $238M | $237M | $261M | $242M | $254M | $285M | $301M | $315M | |
| Shares Outstanding | 53,460,432 | 53,331,766 | 53,331,766 | 52,993,238 | 52,993,238 | 51,954,135 | 51,935,134 | 51,749,504 | 51,522,125 | 51,445,862 | 51,157,636 | 46,143,536 | 45,774,761 | 45,624,860 | 45,622,610 | 45,532,392 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | |
| Operating Cash Flow | $-15M | $-20M | $-17M | $-20M | $-18M | $-18M | $-17M | $-17M | $-2M | $-16M | $-16M | $-13M | $-15M | $-17M | $-14M | $-18M | |
| CapEx | $0 | $0 | $15.0K | $-1.0K | $11.0K | $4.0K | $56.0K | $1.0K | $4.0K | $594.0K | $44.0K | $565.0K | $156.0K | $2M | $4M | $796.0K | |
| Investing Cash Flow | $-12M | $21M | $18M | $12M | $11M | $29M | $8M | $17M | $2M | $26M | $-34M | $-64M | $50M | $30M | $-15M | $-39M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $33M | · | · | · | · | · | |
| Financing Cash Flow | $143.0K | $0 | $392.0K | $0 | $103.0K | $10.0K | $172.0K | $0 | $141.0K | $0 | $33M | $2M | $12.0K | $6.0K | $276.0K | $128.0K | |
| Net Change in Cash | $-27M | $1M | $2M | $-8M | $-7M | $10M | $-9M | $284.0K | $872.0K | $10M | $-16M | $-75M | $35M | $13M | $-29M | $-57M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Free Cash Flow | · | $-20M | · | · | · | $-18M | · | · | · | $-17M | · | · | $-15M | · | · | $-19M |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2396.1% | -1940.7% | · | -1521.8% | -1353.8% | -1114.4% | · | -837.0% | -720.1% | -617.2% | -657.8% | -746.4% | -923.9% | -1723.8% | -2961.1% | -8130.6% | |
| Net Margin | -2295.2% | -1840.6% | · | -1422.9% | -1255.0% | -901.1% | · | -735.2% | -43.3% | -517.3% | -557.6% | -646.7% | -822.7% | -1621.8% | -2865.9% | -8049.3% | |
| Pretax Margin | -2294.8% | -1840.6% | · | -1423.3% | -1254.7% | -1014.6% | · | -732.4% | -620.7% | -517.3% | -557.6% | -646.6% | -822.7% | -1622.6% | -2866.2% | -8048.5% | |
| EBITDA Margin | -2396.1% | -1940.7% | · | -1521.8% | -1353.8% | -1114.4% | · | -837.0% | -720.1% | -617.2% | -657.8% | -746.4% | -923.9% | -1723.8% | -2961.1% | -8130.6% | |
| ROA | -15.4% | -13.5% | · | -11.8% | -10.9% | -8.6% | · | -7.9% | -0.51% | -5.5% | -6.5% | -6.4% | · | -5.8% | -5.3% | -5.5% | |
| ROE | -17.1% | -14.5% | · | -13.2% | -11.9% | -9.3% | · | -8.8% | -0.56% | -6.0% | -7.1% | -7.0% | · | -6.2% | -5.6% | -5.8% | |
| ROIC | -26.4% | · | · | -18.6% | -16.3% | -12.0% | · | -11.1% | -0.66% | · | · | -9.2% | · | -7.4% | -6.5% | -6.4% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.7 | 11.1 | · | 10.8 | 12.5 | 16.8 | · | 14.0 | 19.2 | 16.8 | 19.2 | 16.6 | · | 22.8 | 24.8 | 24.7 | |
| Quick Ratio | 7.5 | 10.9 | · | 10.5 | 12.3 | 16.4 | · | 13.5 | 18.7 | 16.4 | 18.8 | 16.3 | · | 22.2 | 24.4 | 24.2 |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.34 | $1.65 | · | $2.28 | $2.65 | $3.08 | · | $3.82 | $4.16 | $4.13 | $4.64 | $4.72 | · | $5.72 | $6.07 | $6.41 | |
| Revenue / Share | $0.01 | $0.02 | · | $0.03 | $0.03 | $0.04 | · | $0.05 | $0.05 | $0.06 | $0.06 | $0.06 | $0.05 | $0.02 | · | · | |
| Cash Flow / Share | · | $-0.37 | · | · | · | $-0.35 | · | · | · | $-0.31 | · | · | $-0.33 | · | · | · | |
| Cash / Share | $0.23 | $0.73 | · | $0.69 | $0.83 | $0.99 | · | $0.94 | $0.94 | $0.93 | $1.02 | $1.48 | · | $2.19 | $1.91 | $2.54 | |
| EPS (TTM) | $-1.41 | $-1.48 | · | $-1.60 | $-1.57 | $-1.18 | · | $-0.99 | $-0.96 | $-1.32 | $-1.56 | $-1.62 | $-1.62 | $-1.59 | $-1.52 | · |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $5M | · | $7M | $9M | $10M | · | $12M | $12M | $12M | $10M | $8M | $6M | $2M | $1M | $550.0K | |
| Net Income TTM | $-75M | $-78M | · | $-83M | $-81M | $-61M | · | $-51M | $-49M | $-65M | $-73M | $-74M | $-74M | $-72M | $-69M | $-65M | |
| Market Cap | $72M | $66M | · | $74M | $56M | $57M | · | $77M | $83M | $87M | $314M | $289M | · | $543M | $650M | $948M | |
| P/E | -1.0 | -0.8 | · | -0.9 | -0.7 | -0.9 | · | -1.5 | -1.7 | -1.3 | -3.9 | -3.9 | -2.9 | -7.5 | -9.4 | · | |
| P/S | 16.0 | 12.3 | · | 10.0 | 6.6 | 5.9 | · | 6.7 | 7.0 | 7.4 | 32.5 | 37.0 | · | 263.2 | 624.5 | 1723.6 | |
| P/B | 1.0 | 0.8 | · | 0.6 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | 1.3 | 1.3 | · | 2.1 | 2.3 | 3.2 | |
| P / Tangible Book | 1.0 | 0.8 | · | 0.6 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | 1.3 | 1.3 | · | 2.1 | 2.3 | 3.2 | |
| P / Cash Flow | · | -3.4 | · | · | · | -3.1 | · | · | · | -5.4 | · | · | · | · | · | -52.7 | |
| Earnings Yield | -105.2% | -119.3% | · | -114.3% | -148.1% | -108.3% | · | -66.4% | -59.3% | -77.6% | -25.4% | -25.9% | -34.0% | -13.4% | -10.7% | · |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Marge d'exploitation % | -1360.4% | -802.0% | -717.3% | -2124.1% | -12982.8% |
| Résultat net | $-78M | $-59M | $-69M | $-73M | $-58M |
| BPA dilué | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio de liquidité | 10.1 | 12.2 | 14.8 | 22.8 | 24.7 |
| Ratio de liquidité réduite | 9.9 | 11.8 | 14.5 | 22.3 | 24.3 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-74M | $-52M | $-57M | $-72M | $-48M |
Détenteurs institutionnels (13F) 69 déclarants · $47.1M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
69
Valeur détenue
$47.1M
Nouvelles positions
5
Positions clôturées
8
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 5 (-11 vs T. préc.) | 8 (0 vs T. préc.) | 15 (-2 vs T. préc.) | 22 (+4 vs T. préc.) | -2.5M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BML Capital Management, LLC | $7 142 200 | 5 330 000 | 15,18% | Actions |
| TANG CAPITAL MANAGEMENT LLC | $5 688 414 | 4 245 085 | 12,09% | Actions |
| Sio Capital Management, LLC | $3 529 744 | 2 634 137 | 7,50% | Actions |
| Euclidean Capital LLC | $3 521 042 | 2 627 643 | 7,48% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3 162 400 | 2 360 000 | 6,72% | Actions |
| VANGUARD GROUP INC | $2 712 888 | 2 170 310 | 5,77% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $2 696 107 | 2 012 020 | 5,73% | Actions |
| ArrowMark Colorado Holdings LLC | $2 625 836 | 1 959 579 | 5,58% | Actions |
| TWO SIGMA INVESTMENTS, LP | $2 618 542 | 1 954 136 | 5,56% | Actions |
| Eversept Partners, LP | $2 533 811 | 1 890 904 | 5,38% | Actions |
| BlackRock, Inc. | $1 232 556 | 919 818 | 2,62% | Actions |
| TWO SIGMA ADVISERS, LP | $1 092 625 | 874 100 | 2,32% | Actions |
| Stonepine Capital Management, LLC | $718 355 | 536 086 | 1,53% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $634 624 | 473 158 | 1,35% | Actions |
| Aldebaran Capital, LLC | $626 359 | 467 432 | 1,33% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $574 663 | 428 853 | 1,22% | Actions |
| BIT Capital GmbH | $546 124 | 407 555 | 1,16% | Actions |
| Verdad Advisers, LP | $485 564 | 362 361 | 1,03% | Actions |
| Walleye Capital LLC | $449 830 | 335 694 | 0,96% | Actions |
| Assenagon Asset Management S.A. | $442 204 | 330 003 | 0,94% | Actions |
| MARSHALL WACE, LLP | $430 956 | 321 610 | 0,92% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $341 399 | 254 775 | 0,73% | Actions |
| BANK OF AMERICA CORP /DE/ | $321 747 | 240 110 | 0,68% | Actions |
| CITADEL ADVISORS LLC | $271 082 | 202 300 | 0,58% | Option d'achat |
| ADAR1 Capital Management, LLC | $269 351 | 201 008 | 0,57% | Actions |
| STATE STREET CORP | $245 459 | 183 178 | 0,52% | Actions |
| RBF Capital, LLC | $217 348 | 162 200 | 0,46% | Actions |
| GOLDMAN SACHS GROUP INC | $183 572 | 136 994 | 0,39% | Actions |
| MAI Capital Management | $178 383 | 133 122 | 0,38% | Actions |
| Rangeley Capital, LLC | $132 982 | 99 240 | 0,28% | Actions |
| NORTHERN TRUST CORP | $124 683 | 93 047 | 0,26% | Actions |
| Ikarian Capital, LLC | $119 442 | 89 136 | 0,25% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $94 475 | 70 504 | 0,20% | Actions |
| PNC Financial Services Group, Inc. | $91 038 | 67 938 | 0,19% | Actions |
| Quadrature Capital Ltd | $83 174 | 62 070 | 0,18% | Actions |
| Seven Fleet Capital Management LP | $71 782 | 53 569 | 0,15% | Actions |
| CITADEL ADVISORS LLC | $63 393 | 47 308 | 0,13% | Actions |
| Accurate Wealth Management, LLC | $62 000 | 50 000 | 0,13% | Actions |
| Cubist Systematic Strategies, LLC | $61 417 | 43 869 | 0,13% | Actions |
| MORGAN STANLEY | $55 856 | 41 684 | 0,12% | Actions |
| JANE STREET GROUP, LLC | $53 878 | 40 207 | 0,11% | Actions |
| ALGERT GLOBAL LLC | $53 403 | 39 853 | 0,11% | Actions |
| COOPER/HAIMS ADVISORS, LLC | $52 288 | 39 021 | 0,11% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50 292 | 37 531 | 0,11% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $43 496 | 32 460 | 0,09% | Actions |
| Squarepoint Ops LLC | $42 656 | 31 833 | 0,09% | Actions |
| HSBC HOLDINGS PLC | $40 776 | 30 891 | 0,09% | Actions |
| BARCLAYS PLC | $37 201 | 27 761 | 0,08% | Actions |
| BOOTHBAY FUND MANAGEMENT, LLC | $36 349 | 27 126 | 0,08% | Actions |
| Vanguard Global Advisers, LLC | $28 889 | 21 559 | 0,06% | Actions |
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×5 dépôts | 4 mars 2026 | 0,00% | Amendement | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 16 initiés · 5 dirigeants · 9 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Michael Carulli | Chief Financial Officer | 5 mars 2026 A | 60 146 | 0 | 0 | $0 |
| Winston Kung | COO, CFO | 12 mai 2023 A | 10 600 | 0 | 0 | $0 |
| Robert Ticktin | General Counsel & COO | 5 mars 2026 A | 98 695 | 0 | 0 | $0 |
| Deepika Jalota | Chief Development Officer | 5 mars 2026 A | 89 959 | 0 | 0 | $0 |
| Leila Alland | Chief Medical Officer | 15 septembre 2023 S | 45 909 | 0 | 0 | $0 |
| Kirsten Flowers | Administrateur | 4 juin 2026 A | · | 0 | 0 | $0 |
| Laurie Stelzer | Administrateur | 4 juin 2026 A | · | 0 | 0 | $0 |
| Charles M Baum | Administrateur | 4 juin 2026 A | · | 0 | 0 | $0 |
| Carol Giltner Gallagher | Administrateur | 4 juin 2026 G | · | 0 | 0 | $0 |
| Arnold J Levine | Administrateur | 4 juin 2026 A | 409 842 | 0 | 0 | $0 |
| Richard A. Heyman | Administrateur | 5 juin 2025 A | 0 | 0 | 0 | $0 |
| Peter A. Thompson | Administrateur | 2 juin 2022 A | 475 000 | 0 | 0 | $0 |
| Thilo Schroeder | Administrateur | 6 octobre 2021 S | 1 101 283 | 0 | 0 | $0 |
| Arnold L Oronsky | Administrateur | 29 septembre 2020 C | 6 469 911 | 0 | 0 | $0 |
| David Henry Mack | · | 5 mars 2026 A | 451 109 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | · | 29 septembre 2020 C | 760 267 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 3 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
PMVP Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 12 analystes
ACHAT
Objectif médian
$4.00
+123,5%
4 33,3%
Achat fort
7 58,3%
Achat
1 8,3%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
5 analystes · 2026-09-29Objectif moyen $4.20 +134,6%
← En dessous de tous les objectifs
Prix actuel $1.79
Bas$3.00
Moyenne$4.20
Haut$5.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 14, 2026